Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Twist Bioscience (NASDAQ: TWST) has announced the granting of 94,200 restricted stock units (RSUs) to 30 newly hired employees as an inducement for their employment. This action was taken under Twist's Inducement Equity Incentive Plan, in compliance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over a 48-month period, with 25% vesting on the one-year anniversary of the employee's start date and 1/16 vesting quarterly thereafter, contingent on continued employment. This plan is exclusively used for granting equity awards to new hires or those returning after a significant break in employment.
Twist Bioscience (NASDAQ: TWST) ha annunciato l'assegnazione di 94.200 unità di azioni riservate (RSU) a 30 nuovi assunti come incentivo per il loro impiego. Questa azione è stata intrapresa nell'ambito del Piano di Incentivazione Azionaria per Nuovi Assunti di Twist, nel rispetto della Regola di Quotazione del Nasdaq 5635(c)(4). Le RSU si matureranno in un periodo di 48 mesi, con il 25% che matura al primo anniversario della data di assunzione dell'impiegato e 1/16 che matura trimestralmente successivamente, a condizione di un impiego continuativo. Questo piano è utilizzato esclusivamente per concedere premi azionari ai nuovi assunti o a coloro che tornano dopo una pausa significativa nell'impiego.
Twist Bioscience (NASDAQ: TWST) ha anunciado la concesión de 94,200 unidades de acciones restringidas (RSUs) a 30 nuevos empleados como un incentivo para su contratación. Esta acción se realizó bajo el Plan de Incentivos de Equidad para Nuevos Empleados de Twist, cumpliendo con la Regla de Cotización 5635(c)(4) del Nasdaq. Las RSUs se consolidarán durante un período de 48 meses, con un 25% consolidándose en el primer aniversario de la fecha de inicio del empleado y 1/16 consolidándose trimestralmente a partir de entonces, condicionado a la continuidad del empleo. Este plan se utiliza exclusivamente para conceder premios de equidad a nuevos empleados o a aquellos que regresan después de un largo período de inactividad laboral.
트위스트 바이오사이언스 (NASDAQ: TWST)가 94,200개의 제한주식단위 (RSU)를 30명의 신규 채용 직원에게 고용 유인을 위해 지급한다고 발표했습니다. 이 조치는 트위스트의 신규 고용 인센티브 형평성 계획에 따라 수행되었으며, 나스닥 상장 규칙 5635(c)(4)을 준수합니다. RSU는 48개월 동안 만기되며, 직원의 시작일 1주년 기념일에 25%가 만기 되고 이후 분기마다 1/16이 만기됩니다. 이는 지속적인 고용을 조건으로 합니다. 이 계획은 신규 채용자 또는 오랜 공백 후 복귀하는 직원에게만 주식 보상을 제공하는 데 사용됩니다.
Twist Bioscience (NASDAQ: TWST) a annoncé l'attribution de 94 200 unités d'actions restreintes (RSU) à 30 nouveaux employés comme incitation à leur embauche. Cette action a été réalisée dans le cadre du Plan d'Incitation Équitaire pour Nouveaux Embauchés de Twist, en conformité avec la Règle de Cotation 5635(c)(4) du Nasdaq. Les RSU seront acquises sur une période de 48 mois, avec 25 % acquises à l'anniversaire d'un an de la date de début de l'employé et 1/16 acquises trimestriellement par la suite, conditionnées à une poursuite d'emploi. Ce plan est exclusivement utilisé pour accorder des récompenses en actions aux nouvelles recrues ou à ceux qui reviennent après une interruption significative de leur emploi.
Twist Bioscience (NASDAQ: TWST) hat die Gewährung von 94.200 beschränkten Aktieneinheiten (RSUs) an 30 neu eingestellte Mitarbeiter angekündigt, um ihre Anstellung zu fördern. Diese Maßnahme erfolgte im Rahmen des Anreiz-Aktienplans von Twist für neueinstellungen und entspricht der Nasdaq-Listenregel 5635(c)(4). Die RSUs werden über einen Zeitraum von 48 Monaten fällig, wobei 25% am ersten Jahrestag des Beschäftigungsbeginns des Mitarbeiters fällig werden und 1/16 vierteljährlich danach, wobei die fortdauernde Anstellung Voraussetzung ist. Dieser Plan wird ausschließlich verwendet, um Aktienvergaben an Neueinstellungen oder an Rückkehrer nach einer bedeutenden Beschäftigungspause zu gewähren.
- Attraction of new talent with equity incentives
- Alignment of employee interests with company growth through long-term vesting schedule
- Potential dilution of existing shareholders' equity
The inducement plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Twist, or following a bona fide period of non-employment, as an inducement material to such individuals entering into employment with Twist, pursuant to Nasdaq Listing Rule 5635(c)(4).
The RSUs vest over a 48-month period for each employee as follows:
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240806706655/en/
For Investors:
Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com
For Media:
Amanda Houlihan
Communications Manager
774-265-5334
ahoulihan@twistbioscience.com
Source: Twist Bioscience Corporation
FAQ
How many RSUs did Twist Bioscience (TWST) grant to new employees?
What is the vesting schedule for the RSUs granted by Twist Bioscience (TWST)?
Under which plan did Twist Bioscience (TWST) grant these inducement awards?
What is the purpose of Twist Bioscience's (TWST) Inducement Equity Incentive Plan?
